EN
/
JP
News
About Us
About Us
Philosophy/Policy
Board of Directors
History
Company Information
Corporate Governance
Partner
Close
Business Strategy
Business Strategy
Business Model
Life Cycle Management Strategy
Close
Technology
Technology
SLC Transporters
LAT1 Inhibitors
Close
Pipeline
Pipeline
Development Status
Biliary Tract Cancer
Multiple Sclerosis
Other Pipelines
Close
Clinical Trials
Clinical Trials
Biliary Tract Cancer Phase III
JPH034 Phase 1
Close
IR
IR
IR News
Top Message
Disclosure Policy
Financial Highlights
IR Calendar
IR Library
Financial Results
Presentation Materials
IR Materials
Stock Information
Stock Overview
General Meeting of Shareholders
Disclaimer
Close
Contact
EN
/
JP
Close
Top
＞
News Lists
News Lists
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2015.11.24
Certified as “Yokohama Intellectual Property MIRAI Enterprises”
2015.04.01
J-pharma’s licensing strategy regarding our research tool patent
2015.02.17
Announcement of Phase I clinical trial of novel anti-cancer agent JPH203
1
2
3
4
5
6
7
8
